IP And Trademarks 2 October 2026
NIT and IISER Secure Patent for Cotarnine Oral Cancer Formula
Researchers from the National Institute of Technology and the Indian Institute of Science Education and Research have been granted an Indian patent for a novel cotarnine-derived formulation aimed at treating oral cancer. The breakthrough involves designing, synthesising and formulating a new compound that shows promise in targeting malignant cells, marking a significant step forward in indigenous cancer therapeutics development.
Researchers from NIT and IISER have secured an Indian patent for a new cotarnine‑derived oral cancer formulation. The invention focuses on designing, synthesising and formulating a compound that targets oral cancer cells, offering a potential home‑grown treatment option.
- Patent granted: Indian Intellectual Property Office recognizes the formulation’s novelty.
- Research focus: Design, synthesis, and formulation of cotarnine‑based drug.
- Impact: Enhances domestic capability in cancer drug development.
Read the full report here.
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.